Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2016 - 2026)

Amphastar Pharmaceuticals has reported Return on Capital Employed over the past 12 years, most recently at 1.74% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 1306.0% year-over-year to 1.74%; the TTM value through Dec 2025 reached 1.74%, down 1306.0%, while the annual FY2025 figure was 1.8%, 1318.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 1.74% at Amphastar Pharmaceuticals, down from 10.44% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 18.29% in Q1 2023 and troughed at 1.74% in Q4 2025.
  • A 5-year average of 12.84% and a median of 14.92% in 2023 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 1132bps in 2022 and later plummeted -1306bps in 2025.
  • Year by year, Return on Capital Employed stood at 12.53% in 2021, then soared by 34bps to 16.81% in 2022, then decreased by -10bps to 15.11% in 2023, then dropped by -2bps to 14.8% in 2024, then plummeted by -88bps to 1.74% in 2025.
  • Business Quant data shows Return on Capital Employed for AMPH at 1.74% in Q4 2025, 10.44% in Q3 2025, and 12.58% in Q2 2025.